Vincenzo Emanuele Chiuri

Summary

Country: Italy

Publications

  1. ncbi request reprint Clinical and therapeutic perspectives of gene expression profiling for breast cancer
    V E Chiuri
    Oncologia Medica, Ospedale V Fazzi, Lecce
    Ann Oncol 18:vi58-62. 2007
  2. ncbi request reprint Efficacy and safety of the combination of docetaxel (Taxotere) with targeted therapies in the treatment of solid malignancies
    Vincenzo Emanuele Chiuri
    Oncologia Medica, Ospedale V Fazzi, Pizza F Muratore, 73100 Lecce, Italy
    Curr Drug Targets 10:982-1000. 2009
  3. doi request reprint Which patients with estrogen receptor-positive early breast cancer should be treated with adjuvant chemotherapy?
    Vincenzo Emanuele Chiuri
    Oncologia Medica, Ospedale V Fazzi, Lecce, Italy
    Oncology 77:18-22. 2009
  4. ncbi request reprint Which role for EGFR therapy in breast cancer?
    Vito Lorusso
    Medical Oncology Unit, Hospital Vito Fazzi, Lecce, Italy
    Front Biosci (Schol Ed) 4:31-42. 2012
  5. doi request reprint Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
    Andrea Tinelli
    Department of Gynaecology and Obstetrics, Vito Fazzi Hospital, Lecce, Italy
    Cancer Metastasis Rev 29:339-50. 2010

Detail Information

Publications5

  1. ncbi request reprint Clinical and therapeutic perspectives of gene expression profiling for breast cancer
    V E Chiuri
    Oncologia Medica, Ospedale V Fazzi, Lecce
    Ann Oncol 18:vi58-62. 2007
    ..These predictors, however, need to be validated by prospective clinical trials...
  2. ncbi request reprint Efficacy and safety of the combination of docetaxel (Taxotere) with targeted therapies in the treatment of solid malignancies
    Vincenzo Emanuele Chiuri
    Oncologia Medica, Ospedale V Fazzi, Pizza F Muratore, 73100 Lecce, Italy
    Curr Drug Targets 10:982-1000. 2009
    ..Herein we reported the efficacy and safety results of the most significant clinical trials evaluating different combinations and schedules of docetaxel plus biological therapeutics...
  3. doi request reprint Which patients with estrogen receptor-positive early breast cancer should be treated with adjuvant chemotherapy?
    Vincenzo Emanuele Chiuri
    Oncologia Medica, Ospedale V Fazzi, Lecce, Italy
    Oncology 77:18-22. 2009
    ....
  4. ncbi request reprint Which role for EGFR therapy in breast cancer?
    Vito Lorusso
    Medical Oncology Unit, Hospital Vito Fazzi, Lecce, Italy
    Front Biosci (Schol Ed) 4:31-42. 2012
    ..This paper focuses on the therapeutic strategy for treatment of HER2 overexpressing breast cancer in advanced stages of disease, as well as in the adjuvant and neo-adjuvant settings...
  5. doi request reprint Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal
    Andrea Tinelli
    Department of Gynaecology and Obstetrics, Vito Fazzi Hospital, Lecce, Italy
    Cancer Metastasis Rev 29:339-50. 2010
    ..Prophylactic surgery has been shown to effectively decrease cancer risk, and it has the possibility to substantially reduce ovarian cancer mortality...